Skip to main content
UTMD logo

UTMD

Utah Medical Products Inc
$67.96 -0.42 (-0.61%) At close · Jul 10
Market Cap
$216.39M
Shares
3,184,025

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$67.96 Open$68.89 Day$67.87–70.32 52W$53.11–75.75 Avg vol 30d14K Short int139K · 4.4% float · 6.8d Short vol68% DataJan 2020–Jul 2026 Filing10-Q · May 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 12, 2026
Equibles Rating blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 15 · calm Equity put/call 0.55
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +8%
above
Price vs 50-day avg +2%
above
RSI (14) 49
neutral
MACD trend Negative
52-week position 66%
mid-range
Momentum
relative strength
Very Strong
1-month return −1%
trailing
6-month return +13%
trailing
YTD return +22%
this year
Relative strength +4%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $67 › 200d $63 — 50d above 200d
Institutional flow Accumulating
3 of 119 funds reported for Jun 30 · net +80 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.36% of float · ▲ +5.8% MoM · 6.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
119 holders — near 3-yr high, broad support
Squeeze score 71
high risk · 0–100
Fundamentals
Strong
Revenue growth −6%
Y/Y
Gross margin 57%
contracting
EPS growth −12%
Y/Y
Free cash flow $14.3M
Valuation P/E 20.1
below peers
Balance sheet $85.8M
net cash
Quant / Vol
risk profile
Moderate
Volatility 27%
annualized · 1-yr
Max drawdown −16%
past year
ATR 3.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+8% Bullish
Price vs 50-day avg
+2% Bullish
RSI (14)
49 Neutral
MACD trend
Negative Bearish
52-week position
66% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $67 › 200d $63 — 50d above 200d
Institutional flow Accumulating
3 of 119 funds reported for Jun 30 · net +80 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
4.36% of float · ▲ +5.8% MoM · 6.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
119 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $53 Now $68 · 66% 52-wk high $76
vs 200-day avg +8% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
UTMD
Utah Medical Products Inc
this stock
$216.39M +22.0% -5.8% 20.1 4.4%
ISRG
Intuitive Surgical Inc
$144.07B -28.2% +20.5% 49.4 2.1%
MDLN
Medline Inc.
$53.91B -2.3% +11.5% 2.8%
BDX
Becton Dickinson & Co
$41.87B +0.9% +8.2% 57.7 4.1%
ALC
Alcon Inc
$33.07B -14.0% +10.5% 2.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
119
% held
70.6%
Reported
3 of 119
Top holder
BRANDES INVESTMENT PARTNE…
Held Float
View
Held by Funds
Fund positions
139
View
Short & Settlement
Short Interest Rising
Shares short
138.7K
Days to cover
6.8d
Change
+7.6K sh
View
Short Volume
Short vol %
68%
As of
Jul 10, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$66
As of
Jun 1, 2026
View
Off-Exchange
Off-exchange %
47.5%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$38.5M
EPS diluted
$3.48
View
Filings
SEC Filings
Latest
10-Q
Filed
May 12, 2026
This year
6
View
Proposed Sales
Value
$997.6K
Shares
10.0K
Filed
Jun 14, 2023
View

Performance

5D 20D 120D MTD YTD
UTMD -6.6% -0.9% +13.3% -1.5% +22.0%
SPY +1.4% +4.1% +9.1% +1.1% +10.7%
vs SPY -8.0% -5.0% +4.3% -2.6% +11.3%

Capital returns

Latest dividend
$0.31 / share · ex Jun 17, 2026
Raised 1.6%
Paid (TTM)
$1.235 / share · 4 payouts
Dividend yield (TTM, derived)
1.82%

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 706698 CUSIP 917488108 13F (30d) 3 filings 3 filers Visit website Investor relations